Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 2/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5033931 | 1.00 | ALDH1A1 (0.34) | ALDH1A1L3MBTL1TSHRCYP2D6CYP2C19 | |
| SCHEMBL2020872 | 0.75 | TSHR (0.35) | ALDH1A1TSHRCYP2D6CYP2C19HIF1A | |
| SCHEMBL6555695 | 0.75 | ALDH1A1 (0.39) | ALDH1A1L3MBTL1TSHRCYP2D6CYP2C19 | |
| SCHEMBL28011339 | 0.73 | ALDH1A1 (0.37) | ALDH1A1L3MBTL1TSHRCYP2D6CYP2C19 | |
| SCHEMBL9369144 | 0.73 | ALDH1A1 (0.34) | ALDH1A1TSHRCYP2D6CYP2C19HIF1A | |
| SCHEMBL18680877 | 0.70 | CES1 (0.31) | — | |
| SCHEMBL6008936 | 0.70 | ALDH1A1 (0.41) | ALDH1A1L3MBTL1TSHR | |
| SCHEMBL12308958 | 0.69 | CA1 (0.32) | TSHR | |
| SCHEMBL9947157 | 0.69 | CA1 (0.32) | TSHR | |
| Trifluoroacetic Acid SCHEMBL16569295 | 0.68 | NOS1 (0.33) | ALDH1A1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080312220-A1 | Oxadiazole Derivatives with Crth2 Receptor Activity | 7TM PHARMA A/S (DK) | 2008-12-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080312220-A1 | Oxadiazole Derivatives with Crth2 Receptor Activity | HRH2, HRH1, HRH3 | ALDH1A1 1905/4885L3MBTL1 4155/4885TSHR 80/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.